CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Prelude Therapeutics Inc

PRLD
$354MSmall Cap

Next catalyst

Phase 2August 2027

PRT3789

Advanced Solid Tumor

Get an email about PRLD's next catalysts

Track Prelude Therapeutics (PRLD) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

No other upcoming event in our data.

Catalyst Timeline

2 upcoming, 1 past

Earnings
βœ“Completed

PRLD Reports Financial Results

Nov 16, 2026

Filed: 2026-11-16 AccNo: 0001193125-26-462029 Size: 21 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Source
Phase 2Next

PRT3789 Phase 2 Est. Readout

August 2027~PRT37897

Primary completion for PRT3789 trial (NCT06682806) in Advanced Solid Tumor

Source

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaWILMINGTON131 employees
Drug Pipeline

Frequently asked questions

What is in Prelude Therapeutics Inc's drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Prelude Therapeutics Inc's (PRLD) pipeline across Phase 2. Its lead program is PRT3789 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Prelude Therapeutics Inc's next FDA catalyst?β†’

Prelude Therapeutics Inc's (PRLD) next tracked catalyst is a Phase 2 readout expected August 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track PRLD biotech catalysts?β†’

Add PRLD to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Prelude Therapeutics Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply